Chinese Biotech Firm Leto Lab Secures RMB100 Million
October 16, 2020 — 23:26 CST
This Data Is Locked!
This area is available only to Subscribers.
Leto Lab, a biotechnology focused on recobinant protein drugs, has recently completed a series B financing of over RMB100 million yuan. This round of financing... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals